• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三次计时起立行走测试的可靠性

Reliability of the triple-timed up-and-go test.

作者信息

Sanders Donald B, Guptill Jeffrey T, Aleš Kathy L, Hobson-Webb Lisa D, Jacobus David P, Mahmood Riaz, Massey Janice M, Pittman Melissa M, Prather Kristi, Raja Shruti M, Yow Eric, Juel Vern C

机构信息

Neuromuscular Section, Department of Neurology, Duke University Medical Center, Box 3403, Durham, North Carolina, 27710, USA.

Jacobus Pharmaceutical Company, Princeton, New Jersey, USA.

出版信息

Muscle Nerve. 2018 Jan;57(1):136-139. doi: 10.1002/mus.25700. Epub 2017 Jun 6.

DOI:10.1002/mus.25700
PMID:28545168
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5702274/
Abstract

INTRODUCTION

We report the reliability of a new measure, the triple-timed up-and-go (3TUG) test, for assessing clinical function in patients with Lambert-Eaton myasthenia (LEM).

METHODS

Intrarater reproducibility and interrater agreement of the 3TUG test were assessed in 25 control participants, 24 patients with non-LEM neuromuscular disease, and 12 patients with LEM. The coverage probability (CP) method was the primary measure of reproducibility and agreement. The a priori acceptable range was < 20% difference in 3TUG test times and a CP ≥0.90 confirmed agreement.

RESULTS

CP values > 0.90 for intrarater and interrater tests confirmed acceptable reproducibility and agreement for all groups.

DISCUSSION

The 3TUG test is a quick, noninvasive, and reproducible measure that is easy to perform, measures clinically important weakness in LEM patients, and requires little training. Additional evaluation in a larger number of LEM patients is in progress to validate the 3TUG test as a clinical measure in LEM. Muscle Nerve 57: 136-139, 2017.

摘要

引言

我们报告了一种新的测量方法——三次计时起立行走(3TUG)测试,用于评估兰伯特-伊顿肌无力(LEM)患者的临床功能。

方法

在25名对照参与者、24名非LEM神经肌肉疾病患者和12名LEM患者中评估3TUG测试的评分者内再现性和评分者间一致性。覆盖概率(CP)方法是再现性和一致性的主要测量指标。先验可接受范围为3TUG测试时间差异<20%,且CP≥0.90可确认一致性。

结果

评分者内和评分者间测试的CP值>0.90,证实所有组的再现性和一致性均可接受。

讨论

3TUG测试是一种快速、无创且可重复的测量方法,易于实施,可测量LEM患者临床上重要的肌无力,且几乎无需培训。目前正在对更多LEM患者进行进一步评估,以验证3TUG测试作为LEM临床测量方法的有效性。《肌肉与神经》57: 136 - 139, 2017年。

相似文献

1
Reliability of the triple-timed up-and-go test.三次计时起立行走测试的可靠性
Muscle Nerve. 2018 Jan;57(1):136-139. doi: 10.1002/mus.25700. Epub 2017 Jun 6.
2
Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.兰伯特-伊顿肌无力症中三重计时起立行走测试的验证。
Muscle Nerve. 2019 Sep;60(3):292-298. doi: 10.1002/mus.26625. Epub 2019 Jul 18.
3
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.3,4-二氨基吡啶碱能有效治疗 Lambert-Eaton 肌无力症。
Muscle Nerve. 2018 Apr;57(4):561-568. doi: 10.1002/mus.26052. Epub 2018 Feb 2.
4
Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton Myasthenia.3,4-二氨基吡啶游离碱在 Lambert-Eaton 肌无力症患者中的群体药代动力学/药效学。
CPT Pharmacometrics Syst Pharmacol. 2017 Sep;6(9):625-634. doi: 10.1002/psp4.12218. Epub 2017 Jul 24.
5
Treatment for Lambert-Eaton myasthenic syndrome.兰伯特-伊顿肌无力综合征的治疗。
Cochrane Database Syst Rev. 2003(2):CD003279. doi: 10.1002/14651858.CD003279.
6
[Lambert-Eaton syndrome or mixed neuromuscular block: diagnostic difficulties].
Ann Med Interne (Paris). 1995;146(1):55-8.
7
Clinical neurophysiology of disorders of the neuromuscular junction.神经肌肉接头疾病的临床神经生理学
J Clin Neurophysiol. 1993 Apr;10(2):167-80. doi: 10.1097/00004691-199304000-00004.
8
Lambert-Eaton myasthenic syndrome in children.儿童兰伯特-伊顿肌无力综合征
J Child Neurol. 2002 Jan;17(1):74-6. doi: 10.1177/088307380201700123.
9
Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.兰伯特-伊顿肌无力综合征患者对电压门控钙通道的递增反应及抗体的长期观察:两例报告
J Med Case Rep. 2015 Mar 14;9:59. doi: 10.1186/s13256-015-0524-9.
10
Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.婴儿期起病的兰伯特-伊顿肌无力综合征的长期随访
J Child Neurol. 2014 Sep;29(9):NP58-61. doi: 10.1177/0883073813499970. Epub 2013 Oct 10.

引用本文的文献

1
Do we know about dynapenia?我们了解肌肉减少症吗?
North Clin Istanb. 2024 Nov 22;11(6):593-599. doi: 10.14744/nci.2024.48642. eCollection 2024.
2
Assessment of myosteatosis and functionality in pretreatment gynecological cancer patients.评估预处理妇科癌症患者的肌肉脂肪变性和功能。
Support Care Cancer. 2024 May 11;32(6):339. doi: 10.1007/s00520-024-08558-4.
3
Presynaptic Paraneoplastic Disorders of the Neuromuscular Junction: An Update.神经肌肉接头的突触前副肿瘤性疾病:最新进展

本文引用的文献

1
Choice of agreement indices for assessing and improving measurement reproducibility in a core laboratory setting.在核心实验室环境中评估和提高测量再现性时一致性指标的选择。
Stat Methods Med Res. 2016 Dec;25(6):2939-2958. doi: 10.1177/0962280214534651. Epub 2014 May 14.
2
Minimal detectable change of the timed "up & go" test and the dynamic gait index in people with Parkinson disease.帕金森病患者计时“站起-行走”测试和动态步态指数的最小可检测变化。
Phys Ther. 2011 Jan;91(1):114-21. doi: 10.2522/ptj.20090126. Epub 2010 Oct 14.
3
Test-retest reliability and minimal detectable change scores for the timed "up & go" test, the six-minute walk test, and gait speed in people with Alzheimer disease.
Brain Sci. 2021 Aug 3;11(8):1035. doi: 10.3390/brainsci11081035.
4
Assessment of physical function by subjective and objective methods in patients undergoing open gynecologic surgery.采用主观和客观方法评估行开腹妇科手术患者的身体功能。
Gynecol Oncol. 2021 Apr;161(1):83-88. doi: 10.1016/j.ygyno.2021.01.021. Epub 2021 Jan 31.
5
Primary mitochondrial myopathy: Clinical features and outcome measures in 118 cases from Italy.原发性线粒体肌病:来自意大利的118例患者的临床特征及疗效评估
Neurol Genet. 2020 Oct 20;6(6):e519. doi: 10.1212/NXG.0000000000000519. eCollection 2020 Dec.
6
Translation and cross-cultural adaptation of the Charcot-Marie-Tooth disease Pediatric Scale to Brazilian Portuguese and determination of its measurement properties.Charcot-Marie-Tooth 病儿科量表的巴葡译及跨文化调适及其测量特性的测定。
Braz J Phys Ther. 2021 May-Jun;25(3):303-310. doi: 10.1016/j.bjpt.2020.07.008. Epub 2020 Aug 7.
7
Validation of the triple timed up-and-go test in Lambert-Eaton myasthenia.兰伯特-伊顿肌无力症中三重计时起立行走测试的验证。
Muscle Nerve. 2019 Sep;60(3):292-298. doi: 10.1002/mus.26625. Epub 2019 Jul 18.
8
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.3,4-二氨基吡啶碱能有效治疗 Lambert-Eaton 肌无力症。
Muscle Nerve. 2018 Apr;57(4):561-568. doi: 10.1002/mus.26052. Epub 2018 Feb 2.
阿尔茨海默病患者定时“起立行走”测试、六分钟步行测试及步速的重测信度和最小可检测变化值
Phys Ther. 2009 Jun;89(6):569-79. doi: 10.2522/ptj.20080258. Epub 2009 Apr 23.
4
Identifying a cut-off point for normal mobility: a comparison of the timed 'up and go' test in community-dwelling and institutionalised elderly women.确定正常活动能力的临界点:对社区居住和机构养老老年女性定时起立行走测试的比较
Age Ageing. 2003 May;32(3):315-20. doi: 10.1093/ageing/32.3.315.
5
Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds.社区居住老年人与年龄和性别相关的测试表现:六分钟步行测试、伯格平衡量表、定时起立行走测试及步速
Phys Ther. 2002 Feb;82(2):128-37. doi: 10.1093/ptj/82.2.128.
6
Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease.帕金森病患者定时起立行走测试测量结果的可靠性。
Phys Ther. 2001 Feb;81(2):810-8. doi: 10.1093/ptj/81.2.810.
7
Statistical methods for assessing agreement between two methods of clinical measurement.评估两种临床测量方法之间一致性的统计方法。
Lancet. 1986 Feb 8;1(8476):307-10.